Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 32
1.
Zhonghua Liu Xing Bing Xue Za Zhi ; 43(7): 1140-1146, 2022 Jul 10.
Article Zh | MEDLINE | ID: mdl-35856212

Objective: To assess the cost-effectiveness of influenza vaccination among people aged 60 years and older in Shenzhen. Methods: A Markov state transition model was constructed to evaluate the cost-effectiveness of annual influenza vaccination for preventing influenza infection compared with no vaccination among the elderly from the social perspective. Allowing seasonal variation of influenza activity, the model followed a five-year cohort using weekly cycles. We employed once the Chinese gross domestic product (GDP) per capita in 2019 (70 892 yuan) as the willingness-to-pay (WTP) threshold and calculated the net monetary benefit (NMB) with costs and quality-adjusted life-years (QALYs) discounted at 5% annually. The impact of parameter uncertainty on the results was examined using one-way and probabilistic sensitivity analyses (PSA). Results: The base case amounted to approximately 35 yuan of cost-saving and a net gain of 0.007 QALYs. Correspondingly, the NMB was 529 yuan per vaccinated person. One-way sensitivity analyses showed that the NMB was relatively sensitive to changes in the attack rate of influenza and vaccine effectiveness. Based on the results of PSA with 1 000 Monte Carlo simulations, influenza vaccination had a probability of being cost-effective in 100% of the repetitions. Conclusions: The present study provides evidence that influenza vaccination is a cost-saving disease prevention strategy for people aged 60 years and older in Shenzhen.


Influenza Vaccines , Influenza, Human , Aged , Cost-Benefit Analysis , Humans , Influenza Vaccines/therapeutic use , Influenza, Human/prevention & control , Markov Chains , Middle Aged , Quality-Adjusted Life Years , Vaccination/methods
2.
Lupus ; 27(5): 828-836, 2018 Apr.
Article En | MEDLINE | ID: mdl-29301470

Objective The objective of this paper is to identify the risk of complications of real-time ultrasound-guided renal biopsy in adult and pediatric patients with systemic lupus erythematosus (SLE). Materials and methods This retrospective study examined outcomes of 296 renal biopsy procedures in 275 SLE patients. Imaging-confirmed symptomatic hematoma was regarded as a major complication when intervention (blood transfusion, angiographic embolization, or surgery) was required or as a minor complication otherwise. Clinical and laboratory data were compared between groups with or without complications after initial or subsequent renal biopsy. Binary logistic regressions were used to evaluate complication risk of initial renal biopsy. Results Overall complication rate of initial renal biopsy was 8.7% (major: 2.9%, minor: 5.8%). Three patients expired from pulmonary hemorrhage, thrombotic microangiopathy, and pneumonia. Pediatric SLE patients tended to have a higher rate of major complications (12.5%) than adult patients (2.3%). According to multivariable analysis results, elevated serum creatinine (SCr) level (OR 1.45; 95% CI 1.17-1.81 per mg/dl), prolonged prothrombin time (PT) (OR 2.2; 95% CI 1.05-4.62 per second), and thrombocytopenia (OR 4.3; 95% CI 1.56-11.9) increased overall complication risk of initial renal biopsy. Age < 18 years (OR 8.43; 95% CI 1.21-58.8), thrombocytopenia (OR 16.4; 95% CI 2.44-110.5), and elevated SCr level (OR 1.97; 95% CI 1.36-2.86 per md/dl) increased risk of major complications. Thrombocytopenia, prolonged PT, and elevated SCr level were associated with complications after subsequent renal biopsy (all p = 0.01). Conclusions SLE patients, particularly patients under 18 years old or with elevated SCr level, prolonged PT, or thrombocytopenia, have an increased risk of complications after initial or subsequent renal biopsy.


Hematoma/epidemiology , Image-Guided Biopsy/adverse effects , Kidney/pathology , Lupus Erythematosus, Systemic/pathology , Lupus Nephritis/pathology , Ultrasonography, Interventional/adverse effects , Adolescent , Adult , Age Factors , Aged , Biomarkers/blood , Blood Coagulation , Creatinine/blood , Female , Hematoma/blood , Hematoma/diagnostic imaging , Hematoma/therapy , Humans , Logistic Models , Lupus Erythematosus, Systemic/blood , Lupus Erythematosus, Systemic/epidemiology , Lupus Nephritis/blood , Lupus Nephritis/epidemiology , Male , Middle Aged , Multivariate Analysis , Odds Ratio , Predictive Value of Tests , Prevalence , Prothrombin Time , Retrospective Studies , Risk Factors , Taiwan/epidemiology , Thrombocytopenia/epidemiology , Time Factors , Tomography, X-Ray Computed , Young Adult
3.
Eur Rev Med Pharmacol Sci ; 21(24): 5668-5676, 2017 12.
Article En | MEDLINE | ID: mdl-29272001

OBJECTIVE: To determine whether the combination of prostaglandin E2 (PGE2) and EP2, the subtype receptor of PGE2, could trans-activate the epidermal growth factor receptor (EGFR). PATIENTS AND METHODS: In this experiment, we selected epithelial cells from normal esophageal mucosa as the negative control group, and the ESCC EC109 and TE-1 cell strain as the observation group. Real-time PCR and Western-blotting were used to detect the expression of EP2, EGFR and phosphorylated EGFR (p-EGFR). The pre-treatment of ESCC cell strains was carried out using Butaprost (special agonist of PGE2 and EP2) and RNAi of EP2, and we observed the expression of EP2, EGFR, and p-EGFR. WST-8 (CCK-8) was applied for the detection of the cell proliferation rate. The transwell invasion experiment was conducted for the detection of the invasion capability of cells. The expression of MMP-9 (matrix metalloproteinase-9), VEGF (vascular endothelial growth factor), pro-inflammatory factors (IL-6 and TNF-α) in the cell supernatant were detected using ELISA. RESULTS: The high mRNA and protein expression of EP2, EGFR, and p-EGFR were found in the EC109 and TE-1 cell strains in the observation group, which were higher than those in the control group (p < 0.05). After the intervention of PGE2, EP2 expression was decreased and the p-EGFR expression was increased (p < 0.05). There was no variation found in the expression of EGFR (p > 0.05). After cells were intervened using Butaprost, the expressions of EP2 and p-EGFR were increased (p < 0.05), and there were no changes identified in the expression of EGFR (p > 0.05). After the intervention of RNAi, the expression of EP2 and p-EGFR was decreased (p < .05), and no changes were identified in the expression of EGFR (p > 0.05). After the intervention of PGE2 and Butaprost, great increases were seen in the cell proliferation rate, invasion capability, and the expression of MMP-9, VEGF, IL-6, and TNF-α in EC109 and TE-1 cell strains (p < 0.05), however, the intervention of RNAi could reduce above indexes (p < 0.05). CONCLUSIONS: Through cell experiments, we verified that the combination of prostaglandin E2 (PGE2) and EP2, the subtype receptor of PGE2, could trans-activate the epidermal growth factor receptor (EGFR) to regulate the proliferation and invasion capability of esophageal squamous cell carcinoma (ESCC) cells, and secrete and express multiple cytokines, thus discovering the pathological mechanism of inflammation to carcinoma transition in the occurrence of ESCC, and providing the experimental evidence for the search of new target in the treatment of ESCC. ESCC cells can highly express the receptor subtype EP2 of PGE2 that can transactivate the EGFR, through which PGE2 is involved in the transition mechanism from inflammation to cancer.


Alprostadil/analogs & derivatives , Esophageal Neoplasms/pathology , Esophageal Squamous Cell Carcinoma/pathology , Receptors, Prostaglandin E, EP2 Subtype/physiology , Transcriptional Activation , Alprostadil/pharmacology , Cell Line, Tumor , ErbB Receptors/genetics , Humans
4.
Genet Mol Res ; 15(3)2016 Sep 19.
Article En | MEDLINE | ID: mdl-27706747

Melon (Cucumis melo L.) is an important vegetable crop that ranks second in salt tolerance among the Cucurbitaceae. Previous studies on the two muskmelon cultivars 'Bing XueCui' (BXC) and 'Yu Lu' (YL) revealed that they had different characteristics under salt stress, but the molecular basis underlying their different physiological responses is unclear. Here, we combined a physiological study with a genome-wide transcriptome analysis to understand the molecular basis of genetic variation that responds to salt stress in the melon. BXC performed better under salt stress than YL in terms of biomass and photosynthetic characteristics, because it exhibited less reduction in transpiration rate, net photosynthesis rate, and stomatal conductance under 150-mM NaCl stress than YL. A transcriptome comparison of the leaves of the cultivars revealed that 1171 genes responded to salt stress in BXC while 1487 genes were identified as salt-stress-responsive in YL. A real-time polymerase chain reaction analysis of 12 of the responsive genes revealed that there was a strong, positive correlation with RNA sequencing data. The genes were involved in several pathways, including photosynthesis, the biosynthesis of secondary metabolites, metabolism, and plant hormone signal transduction, and their expression levels differed between the two cultivars in response to salt stress. This study provides a molecular perspective of two melon cultivars in response to salt stress, and its results could be used to investigate the complex molecular mechanisms underlying salt tolerance in the melon.


Cucumis melo/physiology , Salt-Tolerant Plants/physiology , Cucumis melo/genetics , Gene Expression , Gene Expression Profiling , Salinity , Salt Tolerance/genetics , Salt-Tolerant Plants/genetics , Stress, Physiological/genetics , Transcriptome
5.
Aliment Pharmacol Ther ; 42(5): 599-606, 2015 Sep.
Article En | MEDLINE | ID: mdl-26096497

BACKGROUND: Controversy exists regarding glucocorticoids therapy and the risk of peptic ulcer bleeding (PUB). AIM: The present study was undertaken to determine whether short-term use of glucocorticoids is associated with the occurrence of peptic ulcer bleeding. METHODS: The records of adult patients hospitalised for newly diagnosed peptic ulcer bleeding from 2000 to 2012 were retrieved from the Taiwan National Health Insurance Research Database, a nationwide population-based registry system. The association between systemic glucocorticoids usage and peptic ulcer bleeding was determined with a conditional logistic regression model comparing cases and controls during time windows of 7, 14 and 28 days using a case-crossover design. RESULTS: Of the 8894 enrolled patients, the adjusted self-matched odds ratios for peptic ulcer bleeding after exposure to the glucocorticoids were 1.37 (95% CI: 1.12-1.68, P = 0.003) for the 7-day window, 1.66 (95% CI: 1.38-2.00, P < 0.001) for the 14-day window and 1.84 (95% CI: 1.57-2.16, P < 0.001) for the 28-day window. Moderate to high, but not low dose glucocorticoids (methylprednisolone <4 mg/day or its equivalence) were associated with an increased risk of peptic ulcer bleeding. Concomitant use of a nonselective nonsteroidal anti-inflammatory drug (NSAID) or aspirin further elevated the risk. However, it does not eliminate the effect of underlying diseases flare-up that may have placed the patients at risk for peptic ulcer bleeding in this kind of study design. CONCLUSIONS: Short-term (7-28 days) exposure to glucocorticoids is significantly associated with peptic ulcer bleeding; this risk seems dose-dependent and is higher when nonselective NSAIDs or aspirin are used concurrently.


Glucocorticoids/adverse effects , Peptic Ulcer Hemorrhage/chemically induced , Adult , Aged , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Aspirin/administration & dosage , Aspirin/adverse effects , Case-Control Studies , Cross-Over Studies , Databases, Factual , Dose-Response Relationship, Drug , Drug Administration Schedule , Drug Combinations , Female , Hospitalization , Humans , Logistic Models , Longitudinal Studies , Male , Middle Aged , Peptic Ulcer Hemorrhage/epidemiology , Research Design , Taiwan/epidemiology , Time Factors
6.
Lupus ; 24(10): 1029-36, 2015 Sep.
Article En | MEDLINE | ID: mdl-25691509

OBJECTIVE: Systemic lupus erythematosus (SLE) is a systemic autoimmune disease and usually requires immunosuppressive therapy, which is a major cause of viral reactivation. The incidence and antiviral response in SLE patients with hepatitis C virus (HCV) reactivation is unclear and needs to be investigated. METHODS: One hundred and sixty-six SLE patients with antibody to HCV (anti-HCV) status were retrospectively reviewed regarding the events of HCV reactivation. Patients with HCV reactivation were treated with pegylated interferon plus ribavirin treatment. The virological response and relapse rate were evaluated. RESULTS: Twenty-six patients were positive for anti-HCV. During a mean 8.4 years of follow-up, 10 (38.5%) cases developed HCV reactivation. No clear relationship was noted between immunosuppressive therapy and the HCV reactivation. Eight patients underwent antiviral therapy and the rapid virological response (RVR), early virological response, and sustained virological response (SVR) rates were 37.5%, 87.5%, and 75.0%, respectively. However, late relapse (reappearance of HCV RNA in serum after archiving SVR) was found in two (33.3%) of six patients achieving SVR. The two cases were HCV genotype 1 b concurrent with corticosteroid treatment. CONCLUSIONS: HCV reactivation in anti-HCV-positive SLE patients was possibly associated with glucocorticoids. The virological response to interferon plus ribavirin treatment is not inferior to the general population. However, monitoring HCV RNA after SVR is necessary for patients concurrent with corticosteroid treatment due to the risk of late relapse.


Antiviral Agents/therapeutic use , Glucocorticoids/adverse effects , Hepacivirus/physiology , Hepatitis C, Chronic/drug therapy , Immunosuppressive Agents/adverse effects , Lupus Erythematosus, Systemic/drug therapy , Virus Activation/drug effects , Adult , Drug Therapy, Combination , Female , Glucocorticoids/therapeutic use , Hepatitis C, Chronic/genetics , Hepatitis C, Chronic/mortality , Humans , Immunosuppressive Agents/therapeutic use , Incidence , Interferon-alpha/therapeutic use , Lupus Erythematosus, Systemic/virology , Male , Middle Aged , RNA, Viral/blood , Recurrence , Retrospective Studies , Ribavirin/therapeutic use , Viral Load/drug effects
7.
Article En | MEDLINE | ID: mdl-19964429

Hypertension is a common clinical disease and a major risk to human health. Many clinical findings indicate that certain types of music can reduce blood pressure (BP), and music therapy is considered as an important part of anti-hypertension treatment. We integrate our former related research achievement into the new MP3 player, which can also detect the current BP value with a cuffless measurement method. According to the current BP value, the MP3 player selects certain types of music for playing in order to alleviate the hypertension of patients.


Blood Pressure Determination/instrumentation , Hypertension/rehabilitation , MP3-Player , Monitoring, Ambulatory/instrumentation , Music Therapy/instrumentation , Therapy, Computer-Assisted/instrumentation , Aged , Aged, 80 and over , Blood Pressure Determination/methods , Equipment Design , Equipment Failure Analysis , Health Services for the Aged/statistics & numerical data , Humans , Hypertension/diagnosis , Music Therapy/methods , Signal Processing, Computer-Assisted/instrumentation , Telemetry/instrumentation
8.
J Neurol Sci ; 277(1-2): 174-5, 2009 Feb 15.
Article En | MEDLINE | ID: mdl-19033078

A 55-year-old man developed ischemic stroke after three episodes of transient dysarthria and left hemiplegia, a typical manifestation of capsular warning syndrome. Magnetic resonance imaging of the brain showed bilateral basal ganglionic infarction. The patient had no significant risk of stroke. However, the systemic manifestations, an elevated titer of perinuclear anti-neutrophilic cytoplasmic antibody and a skin biopsy revealing leukocytoclastic venulitis confirmed the undrlying microscopic polyangiitis.


Basal Ganglia Diseases/etiology , Brain Ischemia/etiology , Stroke/etiology , Vasculitis, Central Nervous System/complications , Vasculitis, Leukocytoclastic, Cutaneous/complications , Basal Ganglia Diseases/pathology , Brain Ischemia/pathology , Diffusion Magnetic Resonance Imaging , Humans , Male , Middle Aged , Stroke/pathology , Vasculitis, Central Nervous System/pathology , Vasculitis, Leukocytoclastic, Cutaneous/pathology
12.
J Intern Med ; 257(6): 561-3, 2005 Jun.
Article En | MEDLINE | ID: mdl-15910561

Mononeuropathy multiplex (MNM) and chylothorax are rare clinical disorders. The concurrence of these two disorders with Mycobacterium tuberculosis infection has not been reported. We herein report a patient who was initially diagnosed with fever of unknown origin and MNM, and then developed chylothorax. Pulmonary tuberculosis was proved 1 month after chylothorax appeared. With low-dose prednisolone 15 mg day(-1) and anti-tuberculosis drugs, all these disorders completely resolved 1 year later.


Chylothorax/etiology , Mononeuropathies/etiology , Tuberculosis, Pulmonary/complications , Aged , Antitubercular Agents/therapeutic use , Chylothorax/drug therapy , Glucocorticoids/therapeutic use , Humans , Male , Mononeuropathies/drug therapy , Prednisolone/therapeutic use , Treatment Outcome , Tuberculosis, Pulmonary/drug therapy
14.
Clin Exp Immunol ; 131(3): 506-16, 2003 Mar.
Article En | MEDLINE | ID: mdl-12605705

Decreased number and impaired functions of polymorphonuclear neutrophils (PMN) due to the presence of anti-PMN autoantibodies in the serum render patients with systemic lupus erythematosus (SLE) susceptible to bacterial infections. However, the cognate antigens and pathological mechanisms of anti-PMN autoantibodies in SLE are rarely reported in the literature. In this study, we found approximately 20% of SLE sera contained anti-PMN autoantibodies detected by human PMN-coated cellular ELISA. A membrane protein with molecular weight of 50 kDa was identified as the cognate antigen of anti-PMN in Western blot after membrane-biotinylation and streptavidin column elution. The 50 kDa molecule was proved to be SSB/La after immunoscreening, molecular cloning and nucleotide sequencing of the gene from the human leucocyte cDNA library. Human anti-SSB/La autoantibodies purified from active SLE sera passing through the recombinant SSB/La conjugated Sepharose 4B affinity column could bind and penetrate into normal human PMN. Functional analysis revealed that the anti-SSB/La autoantibodies exerted a number of potent effects on human PMN, including suppressed phagocytosis, accelerated apoptosis and enhanced IL-8 production. These in vitro results suggest that anti-SSB/La is one of the anti-PMN autoantibodies capable of penetrating into PMN and responsible for neutropenia and functional impairment of PMN in patients with SLE.


Autoantibodies/immunology , Lupus Erythematosus, Systemic/immunology , Neutropenia/immunology , Neutrophils/immunology , Ribonucleoproteins/immunology , Apoptosis/immunology , Autoantibodies/isolation & purification , Autoantibodies/metabolism , Autoantigens/genetics , Autoantigens/immunology , Base Sequence , Chromatography, Affinity , DNA, Complementary/genetics , Gene Expression , Humans , Interleukin-8/biosynthesis , Jurkat Cells , Molecular Sequence Data , Neutrophils/metabolism , Phagocytosis/immunology , Ribonucleoproteins/genetics , SS-B Antigen
15.
Tissue Antigens ; 59(1): 31-7, 2002 Jan.
Article En | MEDLINE | ID: mdl-11972876

Chronic hepatitis C virus (HCV) infection may induce immunological disorders in the host such as the presence of cryoglobulinemia or serum autoantibodies. The pathogenesis of these phenomena remains unclear but may reflect the host's genetic predispositions. The aim of this study was to evaluate the association between these immunological manifestations and human leukocyte antigen (HLA) expression in Chinese patients with chronic hepatitis C. The presence of serum cryoglobulin and autoantibodies (antinuclear antibody, antismooth muscle antibody, antimitochondrial antibody, antiliver-kidney-microsomal antibody) was determined in 122 Chinese patients with chronic hepatitis C. HLA class I and class II antigens were measured by microlymphocytotoxicity assay or by DNA typing in 122 chronic hepatitis C patients and 228 healthy controls. Of the 122 patients with chronic hepatitis C, 52 (43%) had cryoglobulinemia and 48 (39%) had serum autoantibodies. A significant difference in HLA frequency was noted for DR3, which was found in 36.5% of patients with cryoglobulinemia compared with 8.6% of patients without cryoglobulinemia and 11.3% of healthy controls. A significant difference in HLA frequency was also noted for DR4, which was found in 45.8% of patients with serum autoantibodies compared with 17.6% of patients without serum autoantibodies and 19% of healthy controls. Our results suggest the existence of HLA-linked susceptibility genes (DR3 or DR4) for the development of cryoglobulinemia or serum autoantibodies in Chinese patients with chronic hepatitis C.


Autoantibodies/blood , Cryoglobulinemia/genetics , Genetic Predisposition to Disease , Hepatitis C, Chronic/genetics , Hepatitis C, Chronic/immunology , Adult , Aged , Cryoglobulinemia/pathology , Gene Frequency , HLA-A Antigens/genetics , HLA-B Antigens/genetics , HLA-C Antigens/genetics , HLA-DQ Antigens/genetics , HLA-DR Antigens/genetics , Hepatitis C, Chronic/pathology , Humans , Liver Cirrhosis/pathology , Male , Taiwan
16.
Rheumatology (Oxford) ; 40(8): 851-8, 2001 Aug.
Article En | MEDLINE | ID: mdl-11511752

OBJECTIVES: To determine whether anti-double stranded DNA (anti-dsDNA) autoantibody could bind and affect the functions of normal human polymorphonuclear neutrophils (PMN). METHODS: Normal human PMN were incubated with different concentrations of a monoclonal mouse anti-dsDNA antibody (12B3) or mouse isotype-matched IgG2a. The binding of anti-dsDNA and PMN was measured by flow cytometry and interleukin-8 (IL-8) gene expression in PMN was detected by enzyme-linked immunosorbent assay (ELISA) and reverse transcription-polymerase chain reaction (RT-PCR). PMN apoptosis was justified by morphological changes. The cognate antigen(s) of anti-dsDNA on the PMN surface was identified by membrane biotinylation, immunoprecipitation and Western blot. RESULTS: The binding of PMN with anti-dsDNA was much higher than with non-specific mouse IgG2a (70.8 vs 2.0%). Anti-dsDNA at concentrations higher than 12.5 ng/ml significantly enhanced the production and mRNA expression of IL-8 by PMN. However, anti-dsDNA facilitated PMN apoptosis after 3 h incubation. Western blot analysis of biotinylated PMN cell lysates demonstrated that a 50-52 kDa membrane molecule is the cognate antigen of anti-dsDNA. CONCLUSIONS: Anti-dsDNA autoantibody up-regulates IL-8 gene expression and elicits activation-induced cell death (AICD) of human PMN via binding to a 50-52 kDa membrane-expressed molecule.


Antibodies, Antinuclear/physiology , Antibodies, Monoclonal/immunology , Apoptosis , Carrier Proteins/physiology , DNA/immunology , Gene Expression Regulation , Interleukin-8/genetics , Neutrophils/physiology , Animals , Humans , Mice , Up-Regulation
17.
J Gastroenterol Hepatol ; 16(4): 481-3, 2001 Apr.
Article En | MEDLINE | ID: mdl-11354291

Ranitidine is widely used and well tolerated. Ranitidine-related skin eruption is rare and usually mild. We presented two patients who developed Stevens-Johnson syndrome after ranitidine therapy. Before therapy, both patients had severe liver disease and jaundice. The first was a case of ketoconazole-induced hepatitis, and the second was a case of hepatitis C-related liver cirrhosis with hepatocellular carcinoma. Ranitidine was the most likely drug responsible for causing Stevens-Johnson syndrome in these two patients.


Histamine H2 Antagonists/adverse effects , Liver Diseases/drug therapy , Ranitidine/adverse effects , Stevens-Johnson Syndrome/chemically induced , Antifungal Agents/adverse effects , Carcinoma, Hepatocellular/etiology , Chemical and Drug Induced Liver Injury/drug therapy , Female , Hepatitis C/complications , Humans , Jaundice/chemically induced , Ketoconazole/adverse effects , Liver Cirrhosis/complications , Liver Cirrhosis/virology , Liver Diseases/physiopathology , Liver Neoplasms/etiology , Male , Middle Aged , Severity of Illness Index
18.
Clin Exp Rheumatol ; 18(3): 394-6, 2000.
Article En | MEDLINE | ID: mdl-10895381

A 26-year-old male patient with mitral valve prolapse and HLA-B27 antigen received endodontic treatment for dental caries. Two weeks later fever, dysuria, diarrhea, sterile inflammatory arthritis of lower limbs, enthesitis, dactylitis, conjunctivitis, and uveitis consecutively developed. Blood culture performed at the time of active arthritis yielded Streptococcus viridans. He did not have any history of psoriasis, acute infectious diarrhea, chronic inflammatory bowel diseases, or sexually transmitted diseases. Laboratory studies also excluded the possibility of infections by human immunodeficiency virus, hepatitis B or C virus, chlamydia, and streptococci from the upper airway. This report indicates that Streptococcus viridans can be the triggering microorganisms of Reiter's syndrome in some circumstances.


Arthritis, Reactive/immunology , Arthritis, Reactive/microbiology , HLA-B27 Antigen/analysis , Streptococcal Infections/complications , Streptococcal Infections/immunology , Adult , Humans , Male , Mitral Valve Prolapse/immunology , Mitral Valve Prolapse/microbiology
20.
Zhonghua Yi Xue Za Zhi (Taipei) ; 61(8): 496-9, 1998 Aug.
Article En | MEDLINE | ID: mdl-9745168

Wegener's granulomatosis is a necrotizing, granulomatous vasculitis. It usually causes sinusitis, pneumonitis and glomerulonephritis. The common ocular manifestations include conjunctivitis, scleritis, peripheral keratitis and orbital inflammation. We report the case of a 50-year-old woman with Wegener's granulomatosis and very severe ocular complications who underwent bilateral enucleation. The pathologic findings of the eyeballs revealed granulomatous necrotizing scleritis, perivasculitis and granulomatous choroiditis. The last, as far as we know, has not yet been reported.


Choroiditis/etiology , Granulomatosis with Polyangiitis/complications , Female , Granulomatosis with Polyangiitis/pathology , Humans , Middle Aged
...